The potential role of heat shock protein 27 in cardiovascular disease

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 15-24

  Ghayour Mobarhan, Majid ^a   Saber, Hamidreza ^a   Ferns, Gordon A A ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

Biochemical marker; Cardiovascular disease; Chaperone; Heat shock proteins 27; Therapy

Indexed keywords

ANTIGEN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 27 ANTIGEN; HERBIMYCIN A; TEPRENONE; UNCLASSIFIED DRUG; VIMENTIN;

ACTIN FILAMENT; ADAPTIVE IMMUNITY; ANTIBODY TITER; APOPTOSIS; ATHEROGENESIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROTECTION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; EXON; GENE; GENE STRUCTURE; GENETIC TRANSCRIPTION; HEART PROTECTION; HSP27 GENE; HUMAN; IMMUNE RESPONSE; ISCHEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; UPREGULATION;

ATHEROSCLEROSIS; AUTOANTIBODIES; AUTOANTIGENS; CARDIOVASCULAR DISEASES; HSP27 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 80054749586     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.04.005     Document Type: Review

References (165)

1. Ritossa F. A new puffing pattern induced by temperature shock and DNP in drosophila. Cell Mol Life Sci 1962, 18:571-573.
2. Pesonen E., Paakkari I., Rapola J. Infection-associated intimal thickening in the coronary arteries of children. Atherosclerosis 1999, 142:425-429.
3. Mattila K.J., Nieminen M.S., Valtonen V.V., et al. Association between dental health and acute myocardial infarction. BMJ 1989, 298:779-781.
4. Hu Z., Yang B., Lu W., et al. HSPB2/MKBP, a novel and unique member of the small heat-shock protein family. J Neurosci Res 2008, 86:2125-2133.
5. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997, 337:1360-1369.
6. Breslow J.L. Cardiovascular disease burden increases, NIH funding decreases. Nat Med 1997, 3:600-601.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
8. Ferns G.A. Multiple step-variable pathway hypothesis: a reason why predictions fail in atherosclerosis. Med Hypotheses 2008, 71:923-926.
9. Jozefowicz-Okonkwo G., Wierzbowska-Drabik K., Kasielski M., et al. Is Hsp27 a marker of myocardial ischaemia?. Kardiol Pol 2009, 67:947-952.
10. Arrigo A.P., Welch W.J. Characterization and purification of the small 28,000-dalton mammalian heat shock protein. J Biol Chem 1987, 262:15359-15369.
11. Boelens W.C., Van Boekel M.A., De Jong W.W. HspB3, the most deviating of the six known human small heat shock proteins. Biochim Biophys Acta 1998, 1388:513-516.
12. Ingolia T.D., Craig E.A. Four small Drosophila heat shock proteins are related to each other and to mammalian alpha-crystallin. Proc Natl Acad Sci USA 1982, 79:2360-2364.
13. Iwaki A., Nagano T., Nakagawa M., Iwaki T., Fukumaki Y. Identification and characterization of the gene encoding a new member of the alpha-crystallin/small hsp family, closely linked to the alphaB-crystallin gene in a head-to-head manner. Genomics 1997, 45:386-394.
14. Kappe G., Verschuure P., Philipsen R.L., et al. Characterization of two novel human small heat shock proteins: protein kinase-related HspB8 and testis-specific HspB9. Biochim Biophys Acta 2001, 1520:1-6.
15. Kato K., Goto S., Inaguma Y., Hasegawa K., Morishita R., Asano T. Purification and characterization of a 20-kDa protein that is highly homologous to alpha B crystallin. J Biol Chem 1994, 269:15302-15309.
16. Klemenz R., Frohli E., Steiger R.H., Schafer R., Aoyama A. Alpha B-crystallin is a small heat shock protein. Proc Natl Acad Sci USA 1991, 88:3652-3656.
17. Krief S., Faivre J.F., Robert P., et al. Identification and characterization of cvHsp. A novel human small stress protein selectively expressed in cardiovascular and insulin-sensitive tissues. J Biol Chem 1999, 274:36592-36600.
18. Kappe G., Franck E., Verschuure P., Boelens W.C., Leunissen J.A., De Jong W.W. The human genome encodes 10 alpha-crystallin-related small heat shock proteins: HspB1-10. Cell Stress Chaperones 2003, 8:53-61.
19. Salinthone S., Tyagi M., Gerthoffer W.T. Small heat shock proteins in smooth muscle. Pharmacol Ther 2008, 119:44-54.
20. Hickey E., Brandon S.E., Potter R., Stein G., Stein J., Weber L.A. Sequence and organization of genes encoding the human 27kDa heat shock protein. Nucleic Acids Res 1986, 14:4127-4145.
21. Trinklein N.D., Chen W.C., Kingston R.E., Myers R.M. Transcriptional regulation and binding of heat shock factor 1 and heat shock factor 2 to 32 human heat shock genes during thermal stress and differentiation. Cell Stress Chaperones 2004, 9:21-28.
22. Nakagomi S., Suzuki Y., Namikawa K., Kiryu-Seo S., Kiyama H. Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation. J Neurosci 2003, 23:5187-5196.
23. Wang H., Lin G., Zhang Z. ATF5 promotes cell survival through transcriptional activation of Hsp27 in H9c2 cells. Cell Biol Int 2007, 31:1309-1315.
24. Wilkerson D.C., Skaggs H.S., Sarge K.D. HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression. Cell Stress Chaperones 2007, 12:283-290.
25. Whitlock N.A., Agarwal N., Ma J.X., Crosson C.E. Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci 2005, 46:1092-1098.
26. Lavoie J.N., Lambert H., Hickey E., Weber L.A., Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 1995, 15:505-516.
27. Zantema A., Verlaan-De V.M., Maasdam D., Bol S., van der Eb A. Heat shock protein 27 and alpha B-crystallin can form a complex, which dissociates by heat shock. J Biol Chem 1992, 267:12936-12941.
28. Landry J., Lambert H., Zhou M., et al. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem 1992, 267:794-803.
29. Ludwig S., Engel K., Hoffmeyer A., et al. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol 1996, 16:6687-6697.
30. Stokoe D., Engel K., Campbell D.G., Cohen P., Gaestel M. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 1992, 313:307-313.
31. Freshney N.W., Rawlinson L., Guesdon F., et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994, 78:1039-1049.
32. De Jong W.W., Leunissen J.A., Voorter C.E. Evolution of the alpha-crystallin/small heat-shock protein family. Mol Biol Evol 1993, 10:103-126.
33. Lambert H., Charette S.J., Bernier A.F., Guimond A., Landry J. HSP27 multimerization mediated by phosphorylation-sensitive intermolecular interactions at the amino terminus. J Biol Chem 1999, 274:9378-9385.
34. Theriault J.R., Lambert H., Chavez-Zobel A.T., Charest G., Lavigne P., Landry J. Essential role of the NH2-terminal WD/EPF motif in the phosphorylation-activated protective function of mammalian Hsp27. J Biol Chem 2004, 279:23463-23471.
35. Singh K., Zewge D., Groth-Vasselli B., Farnsworth P.N. A comparison of structural relationships among alpha-crystallin, human Hsp27, gamma-crystallins and beta B2-crystallin. Int J Biol Macromol 1996, 19:227-233.
36. Liu C., Welsh M.J. Identification of a site of Hsp27 binding with Hsp27 and alpha B-crystallin as indicated by the yeast two-hybrid system. Biochem Biophys Res Commun 1999, 255:256-261.
37. Rogalla T., Ehrnsperger M., Preville X., et al. Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem 1999, 274:18947-18956.
38. Doppler H., Storz P., Li J., Comb M.J., Toker A. A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J Biol Chem 2005, 280:15013-15019.
39. Kato M., Herz F., Brijlall D., Kato S. Divergent effects of hyperosmolality on stress-response (heat shock) protein expression in cultured human tumor cells: an immunocytochemical study. Experientia 1994, 50:479-482.
40. Cairns J., Qin S., Philp R., Tan Y.H., Guy G.R. Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A. J Biol Chem 1994, 269:9176-9183.
41. Loktionova S.A., Kabakov A.E. Phosphatase inhibitors prevent HSP27 dephosphorylation, destruction of stress fibrils, and morphological changes in endothelial cells during ATP depletion. Bull Exp Biol Med 2001, 132:914-917.
42. Armstrong S.C., Delacey M., Ganote C.E. Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J Mol Cell Cardiol 1999, 31:555-567.
43. Tar K., Csortos C., Czikora I., et al. Role of protein phosphatase 2A in the regulation of endothelial cell cytoskeleton structure. J Cell Biochem 2006, 98:931-953.
44. Mehlen P., Hickey E., Weber L.A., Arrigo A.P. Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells. Biochem Biophys Res Commun 1997, 241:187-192.
45. Maizels E.T., Peters C.A., Kline M., Cutler R.E., Shanmugam M., Hunzicker-Dunn M. Heat-shock protein-25/27 phosphorylation by the delta isoform of protein kinase C. Biochem J 1998, 332(Pt 3):703-712.
46. Kato K., Ito H., Iwamoto I., Lida K., Inaguma Y. Protein kinase inhibitors can suppress stress-induced dissociation of Hsp27. Cell Stress Chaperones 2001, 6:16-20.
47. Tucker N.R., Ustyugov A., Bryantsev A.L., Konkel M.E., Shelden E.A. Hsp27 is persistently expressed in zebrafish skeletal and cardiac muscle tissues but dispensable for their morphogenesis. Cell Stress Chaperones 2009, 14:521-533.
48. Brown D.D., Christine K.S., Showell C., Conlon F.L. Small heat shock protein Hsp27 is required for proper heart tube formation. Genesis 2007, 45:667-678.
49. Snoeckx L.H., Cornelussen R.N., Van Nieuwenhoven F.A., Reneman R.S., Van Der Vusse G.J. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 2001, 81:1461-1497.
50. Carper S.W., Rocheleau T.A., Cimino D., Storm F.K. Heat shock protein 27 stimulates recovery of RNA and protein synthesis following a heat shock. J Cell Biochem 1997, 66:153-164.
51. Samali A., Gorman A.M., Cotter T.G. Apoptosis - the story so far. Experientia 1996, 52:933-941.
52. Arrigo A.P., Simon S., Gibert B., et al. Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett 2007, 581:3665-3674.
53. Benn S.C., Perrelet D., Kato A.C., et al. Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival. Neuron 2002, 36:45-56.
54. de G.M., Tijdens I., Cramer R., Corless S., Timms J.F., van de Water B. Heat shock protein 27 is the major differentially phosphorylated protein involved in renal epithelial cellular stress response and controls focal adhesion organization and apoptosis. J Biol Chem 2005, 280:29885-29898.
55. Paul C., Manero F., Gonin S., Kretz-Remy C., Virot S., Arrigo A.P. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol 2002, 22:816-834.
56. Chauhan D., Li G., Hideshima T., et al. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance. Blood 2003, 102:3379-3386.
57. Arrigo A.P. sHsp as novel regulators of programmed cell death and tumorigenicity. Pathol Biol Paris 2000, 48:280-288.
58. Bruey J.M., Ducasse C., Bonniaud P., et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000, 2:645-652.
59. Concannon C.G., Orrenius S., Samali A. Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c. Gene Expr 2001, 9:195-201.
60. Beissinger M., Buchner J. How chaperones fold proteins. Biol Chem 1998, 379:245-259.
61. Ehrnsperger M., Graber S., Gaestel M., Buchner J. Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J 1997, 16:221-229.
62. Parcellier A., Schmitt E., Gurbuxani S., et al. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 2003, 23:5790-5802.
63. Jakob U., Gaestel M., Engel K., Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem 1993, 268:1517-1520.
64. Kampinga H.H., Brunsting J.F., Stege G.J., Konings A.W., Landry J. Cells overexpressing Hsp27 show accelerated recovery from heat-induced nuclear protein aggregation. Biochem Biophys Res Commun 1994, 204:1170-1177.
65. Merck K.B., Groenen P.J., Voorter C.E., et al. Structural and functional similarities of bovine alpha-crystallin and mouse small heat-shock protein. A family of chaperones. J Biol Chem 1993, 268:1046-1052.
66. Pivovarova A.V., Mikhailova V.V., Chernik I.S., Chebotareva N.A., Levitsky D.I., Gusev N.B. Effects of small heat shock proteins on the thermal denaturation and aggregation of F-actin. Biochem Biophys Res Commun 2005, 331:1548-1553.
67. Soldatenkov V.A., Dritschilo A. Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins. Cancer Res 1997, 57:3881-3885.
68. Ahmed N.N., Grimes H.L., Bellacosa A., Chan T.O., Tsichlis P.N. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 1997, 94:3627-3632.
69. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997, 385:544-548.
70. Kennedy S.G., Wagner A.J., Conzen S.D., et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 1997, 11:701-713.
71. Khwaja A., Rodriguez-Viciana P., Wennstrom S., Warne P.H., Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997, 16:2783-2793.
72. Kulik G., Klippel A., Weber M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997, 17:1595-1606.
73. Garrido C., Mehlen P., Fromentin A., et al. Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27. Eur J Biochem 1996, 237:653-659.
74. Garrido C., Ottavi P., Fromentin A., et al. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 1997, 57:2661-2667.
75. Mehlen P., Kretz-Remy C., Preville X., Arrigo A.P. Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J 1996, 15:2695-2706.
76. Samali A., Cotter T.G. Heat shock proteins increase resistance to apoptosis. Exp Cell Res 1996, 223:163-170.
77. Keezer S.M., Ivie S.E., Krutzsch H.C., Tandle A., Libutti S.K., Roberts D.D. Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res 2003, 63:6405-6412.
78. Piotrowicz R.S., Hickey E., Levin E.G. Heat shock protein 27kDa expression and phosphorylation regulates endothelial cell migration. FASEB J 1998, 12:1481-1490.
79. Hirano S., Shelden E.A., Gilmont R.R. HSP27 regulates fibroblast adhesion, motility, and matrix contraction. Cell Stress Chaperones 2004, 9:29-37.
80. Shu C.W., Cheng N.L., Chang W.M., Tseng T.L., Lai Y.K. Transactivation of hsp70-1/2 in geldanamycin-treated human non-small cell lung cancer H460 cells: involvement of intracellular calcium and protein kinase C. J Cell Biochem 2005, 94:1199-1209.
81. Butt E., Immler D., Meyer H.E., Kotlyarov A., Laass K., Gaestel M. Heat shock protein 27 is a substrate of cGMP-dependent protein kinase in intact human platelets: phosphorylation-induced actin polymerization caused by HSP27 mutants. J Biol Chem 2001, 276:7108-7113.
82. Polanowska-Grabowska R., Gear A.R. Heat-shock proteins and platelet function. Platelets 2000, 11:6-22.
83. Arrigo A.P., Firdaus W.J., Mellier G., et al. Cytotoxic effects induced by oxidative stress in cultured mammalian cells and protection provided by Hsp27 expression. Methods 2005, 35:126-138.
84. Arata S., Hamaguchi S., Nose K. Effects of the overexpression of the small heat shock protein, HSP27, on the sensitivity of human fibroblast cells exposed to oxidative stress. J Cell Physiol 1995, 163:458-465.
85. Arata S., Hamaguchi S., Nose K. Inhibition of colony formation of NIH 3T3 cells by the expression of the small molecular weight heat shock protein HSP27: involvement of its phosphorylation and aggregation at the C-terminal region. J Cell Physiol 1997, 170:19-26.
86. Doshi B.M., Hightower L.E., Lee J. The role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shock. Cell Stress Chaperones 2009, 14:445-457.
87. Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112:453-465.
88. Elkind M.S. Impact of innate inflammation in population studies. Ann NY Acad Sci 2010, 1207:97-106.
89. Virchow R. Der Ateromatose Prozess der Arterien. Wien Med Wochenschr 1856, 6:825-827.
90. Xu Q.B., Oberhuber G., Gruschwitz M., Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 1990, 56:344-359.
91. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991, 64:5-15.
92. Napoli C., D'Armiento F.P., Mancini F.P., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997, 100:2680-2690.
93. Millonig G., Niederegger H., Rabl W., et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 2001, 21:503-508.
94. Buono C., Come C.E., Stavrakis G., Maguire G.F., Connelly P.W., Lichtman A.H. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler Thromb Vasc Biol 2003, 23:454-460.
95. Kleindienst R., Xu Q., Willeit J., Waldenberger F.R., Weimann S., Wick G. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993, 142:1927-1937.
96. van der Wal A.C., Das P.K., Bentz vdB, van der Loos C.M., Becker A.E. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989, 61:166-170.
97. Kiechl S., Egger G., Mayr M., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103:1064-1070.
98. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001, 285:2481-2485.
99. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
100. Rifai N., Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001, 47:403-411.
101. Yu H., Rifai N. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem 2000, 33:601-610.
102. Poston R.N., Haskard D.O., Coucher J.R., Gall N.P., Johnson-Tidey R.R. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992, 140:665-673.
103. Torzewski J., Oldroyd R., Lachmann P., Fitzsimmons C., Proudfoot D., Bowyer D. Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 1996, 16:673-677.
104. Torzewski J., Bowyer D.E., Waltenberger J., Fitzsimmons C. Processes in atherogenesis: complement activation. Atherosclerosis 1997, 132:131-138.
105. Torzewski M., Torzewski J., Bowyer D.E., et al. Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1997, 17:2448-2452.
106. Wieland E., Dorweiler B., Bonitz U., Lieser S., Walev I., Bhakdi S. Complement activation by oxidatively modified low-density lipoproteins. Eur J Clin Invest 1999, 29:835-841.
107. Prohaszka Z., Duba J., Lakos G., et al. Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol 1999, 11:1363-1370.
108. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q. Is atherosclerosis an immunologically mediated disease?. Immunol Today 1995, 16:27-33.
109. Ghayour-Mobarhan M., Rahsepar A.A., Tavallaie S., Rahsepar S., Ferns G.A. The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv Clin Chem 2009, 48:27-72.
110. Lamb D.J., El-Sankary W., Ferns G.A. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 2003, 167:177-185.
111. Mayr M., Metzler B., Kiechl S., et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999, 99:1560-1566.
112. Lamb D.J., Ferns G.A. The magnitude of the immune response to heat shock protein-65 following BCG immunisation is associated with the extent of experimental atherosclerosis. Atherosclerosis 2002, 165:231-240.
113. Wick G. The heat is on: heat-shock proteins and atherosclerosis. Circulation 2006, 114:870-872.
114. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
115. Lijnen H.R. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001, 86:324-333.
116. Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110:2216-2219.
117. De A.K., Kodys K.M., Yeh B.S., Miller-Graziano C. Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus. J Immunol 2000, 165:3951-3958.
118. George J., Shoenfeld Y., Afek A., et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol 1999, 19:505-510.
119. Xu Q., Dietrich H., Steiner H.J., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992, 12:789-799.
120. Mayr M., Kiechl S., Willeit J., Wick G., Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000, 102:833-839.
121. Xu Q., Kiechl S., Mayr M., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999, 100:1169-1174.
122. Hoppichler F., Lechleitner M., Traweger C., et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 1996, 126:333-338.
123. Vivanco F., Padial L.R., Darde V.M., et al. Proteomic Biomarkers of Atherosclerosis. Biomarker Insights 2008, 3:101-113.
124. De Souza A.I., Wait R., Mitchell A.G., Banner N.R., Dunn M.J., Rose M.L. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ Res 2005, 97:192-198.
125. Walsh K., Smith R.C., Kim H.S. Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. Circ Res 2000, 87:184-188.
126. Wisniewski D., LoGrasso P., Calaycay J., Marcy A. Assay for IkappaB kinases using an in vivo biotinylated IkappaB protein substrate. Anal Biochem 1999, 274:220-228.
127. Vivanco F., Martin-Ventura J.L., Duran M.C., et al. Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res 2005, 4:1181-1191.
128. Martin-Ventura J.L., Blanco-Colio L.M., Munoz-Garcia B., et al. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. Stroke 2004, 35:458-463.
129. Michel J.B. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003, 23:2146-2154.
130. Garcia-Touchard A., Henry T.D., Sangiorgi G., et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 2005, 25:1119-1127.
131. Rossignol P., Luttun A., Martin-Ventura J.L., et al. Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost 2006, 4:664-670.
132. Martin-Ventura J.L., Nicolas V., Houard X., et al. Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:1337-1343.
133. McGregor E., Kempster L., Wait R., Gosling M., Dunn M.J., Powell J.T. F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol Cell Proteomics 2004, 3:115-124.
134. Dohke T., Wada A., Isono T., et al. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Card Fail 2006, 12:77-84.
135. Pawlowska Z., Baranska P., Jerczynska H., Koziolkiewicz W., Cierniewski C.S. Heat shock proteins and other components of cellular machinery for protein synthesis are up-regulated in vascular endothelial cell growth factor-activated human endothelial cells. Proteomics 2005, 5:1217-1227.
136. White M.Y., Hambly B.D., Jeremy R.W., Cordwell S.J. Ischemia-specific phosphorylation and myofilament translocation of heat shock protein 27 precedes alpha B-crystallin and occurs independently of reactive oxygen species in rabbit myocardium. J Mol Cell Cardiol 2006, 40:761-774.
137. Martin J.L., Mestril R., Hilal-Dandan R., Brunton L.L., Dillmann W.H. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 1997, 96:4343-4348.
138. Martin J.L., Hickey E., Weber L.A., Dillmann W.H., Mestril R. Influence of phosphorylation and oligomerization on the protective role of the small heat shock protein 27 in rat adult cardiomyocytes. Gene Expr 1999, 7:349-355.
139. Hollander J.M., Martin J.L., Belke D.D., et al. Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 2004, 110:3544-3552.
140. Clements R.T., Sodha N.R., Feng J., et al. Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass. J Thorac Cardiovasc Surg 2007, 134:1461-1470.
141. Somara S., Bitar K.N. Tropomyosin interacts with phosphorylated HSP27 in agonist-induced contraction of smooth muscle. Am J Physiol Cell Physiol 2004, 286:C1290-C1301.
142. Chen H., Wu X.J., Lu X.Y., et al. Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats. Acta Pharmacol Sin 2005, 26:806-812.
143. Lee J.S., Zhang M.H., Yun E.K., et al. Heat shock protein 27 interacts with vimentin and prevents insolubilization of vimentin subunits induced by cadmium. Exp Mol Med 2005, 37:427-435.
144. Robinson A.A., Dunn M.J., McCormack A., dos Remedios C., Rose M.L. Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization. J Mol Cell Cardiol 2010, 49:370-379.
145. Feil S., Hofmann F., Feil R. SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ Res 2004, 94:863-865.
146. Kardys I., Rifai N., Meilhac O., et al. Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. Clin Chem 2008, 54:139-146.
147. Xu Q., Schett G., Perschinka H., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000, 102:14-20.
148. Xu Q., Willeit J., Marosi M., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993, 341:255-259.
149. Ghayour-Mobarhan M., Sahebkar A., Parizadeh S.M., et al. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int J Exp Pathol 2008, 89:209-215.
150. Shamaei-Tousi A., Stephens J.W., Bin R., et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J 2006, 27:1565-1570.
151. Zhu J., Quyyumi A.A., Rott D., et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001, 103:1071-1075.
152. Metzler B., Schett G., Kleindienst R., et al. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol 1997, 17:536-541.
153. Burian K., Kis Z., Virok D., et al. Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2001, 103:1503-1508.
154. Birnie D.H., Hood S., Holmes E., Hillis W.S. Anti-heat shock protein 65 titres in acute myocardial infarction. Lancet 1994, 344:1443.
155. Park H.K., Park E.C., Bae S.W., et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006, 114:886-893.
156. Vander Heide R.S. Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2002, 282:H935-H941.
157. Dybdahl B., Slordahl S.A., Waage A., Kierulf P., Espevik T., Sundan A. Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 2005, 91:299-304.
158. Knowlton A.A. The role of heat shock proteins in the heart. J Mol Cell Cardiol 1995, 27:121-131.
159. Shams S., Shafi S., Bodman-Smith K., Williams P., Mehta S., Ferns G.A. Anti-heat shock protein-27 (Hsp-27) antibody levels in patients with chest pain: association with established cardiovascular risk factors. Clin Chim Acta 2008, 395:42-46.
160. Yamboliev I.A., Hedges J.C., Mutnick J.L., Adam L.P., Gerthoffer W.T. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ Physiol 2000, 278:H1899-H1907.
161. Pourghadamyari H., Moohebati M., Parizadeh S.M., et al. Serum antibody titers against heat shock protein 27 are associated with the severity of coronary artery disease 2010, Cell Stress Chaperones.
162. Azarpazhooh M.R., Mobarra N., Parizadeh S.M., et al. Serum high-sensitivity C-reactive protein and heat shock protein 27 antibody titers in patients with stroke and 6-month prognosis. Angiology 2010, 61:607-612.
163. Dillmann W.H. Small heat shock proteins and protection against injury. Ann NY Acad Sci 1999, 874:66-68.
164. Miller H., Poon S., Hibbert B., Rayner K., Chen Y.X., O'Brien E.R. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens. Arterioscler Thromb Vasc Biol 2005, 25:e10-e14.
165. Brundel B.J., Ke L., Dijkhuis A.J., et al. Heat shock proteins as molecular targets for intervention in atrial fibrillation. Cardiovasc Res 2008, 78:422-428.